These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 24902976)

  • 1. Antiplatelet and anticoagulation therapy for acute coronary syndromes.
    Bhatt DL; Hulot JS; Moliterno DJ; Harrington RA
    Circ Res; 2014 Jun; 114(12):1929-43. PubMed ID: 24902976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet and anticoagulant strategies in acute coronary syndrome: where we are in 2013.
    Lumley M; Perera D
    Future Cardiol; 2013 May; 9(3):371-85. PubMed ID: 23668742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding and the use of antiplatelet agents in the management of acute coronary syndromes and atrial fibrillation.
    Vavalle JP; Rao SV
    Adv Cardiol; 2012; 47():125-40. PubMed ID: 22906908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of antiplatelet agents and anticoagulants for cardiovascular disease: current standards and best practices.
    Faxon DP
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S3-14. PubMed ID: 17710074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailored antithrombotic therapy for acute coronary syndromes.
    Fitchett D
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):935-44. PubMed ID: 18666844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of new oral anticoagulants with dual antiplatelet therapy in patients with acute coronary syndromes.
    Tsu LV; Dager WE
    Ann Pharmacother; 2013 Apr; 47(4):573-7. PubMed ID: 23548645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of home warfarin use on treatment patterns and bleeding complications for patients with non-ST-segment elevation acute coronary syndromes: observations from the CRUSADE quality improvement initiative.
    Wang TY; Chen AY; Peterson ED; Becker RC; Gibler WB; Ohman EM; Roe MT
    Eur Heart J; 2008 May; 29(9):1103-9. PubMed ID: 18353757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet intervention in acute coronary syndrome.
    Arora RR; Rai F
    Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotics in acute coronary syndromes.
    Bonaca MP; Steg PG; Feldman LJ; Canales JF; Ferguson JJ; Wallentin L; Califf RM; Harrington RA; Giugliano RP
    J Am Coll Cardiol; 2009 Sep; 54(11):969-84. PubMed ID: 19729112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet agents in acute coronary syndromes.
    Sakhuja R; Yeh RW; Bhatt DL
    Curr Probl Cardiol; 2010 Mar; 35(3):123-70. PubMed ID: 20152547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prasugrel for acute and long-term treatment of patients with acute coronary syndromes: what is state-of-the-art?].
    Silber S; Helms TM; Garlichs C; Arntz HR; Weil J; Ince H; Klingenheben T; Hoffmann S; Boudriot E; Steiger H; Zugck C
    Dtsch Med Wochenschr; 2011 Apr; 136(15):782-5. PubMed ID: 21432747
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anticoagulants and dual antiplatelet therapy combined, a challenge to our intelligence].
    Morais J
    Rev Port Cardiol; 2012 Apr; 31 Suppl 1():38-44. PubMed ID: 22541034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet therapy in acute coronary syndrome and atrial fibrillation: aspirin.
    Tanguay JF
    Adv Cardiol; 2012; 47():20-30. PubMed ID: 22906900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updates in antiplatelet agents used in cardiovascular diseases.
    Cheng JW
    J Cardiovasc Pharmacol Ther; 2013 Nov; 18(6):514-24. PubMed ID: 24213473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral antiplatelet therapy in unstable angina/non-ST-segment elevation myocardial infarction, ST-segment elevation myocardial infarction, and percutaneous coronary intervention: is it time for a guideline update?
    Saucedo JF
    Am J Cardiol; 2009 Sep; 104(5 Suppl):4C-8C. PubMed ID: 19695354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of antiplatelet therapy in heart disease.
    Renda G; de Caterina R
    Adv Cardiol; 2012; 47():5-19. PubMed ID: 22906899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
    Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
    Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
    Antman EM; Wiviott SD; Murphy SA; Voitk J; Hasin Y; Widimsky P; Chandna H; Macias W; McCabe CH; Braunwald E
    J Am Coll Cardiol; 2008 May; 51(21):2028-33. PubMed ID: 18498956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel antiplatelet strategies in acute coronary syndromes.
    Sabatine MS
    Cleve Clin J Med; 2009 Apr; 76 Suppl 1():S8-15. PubMed ID: 19332592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platelet aggregation and antiplatelet agents in acute coronary syndromes].
    Collet JP; Choussat R; Montalescot G
    Med Sci (Paris); 2004 Mar; 20(3):291-7. PubMed ID: 15067573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.